Influenza pandemic planning for cancer patients
Identifieur interne : 000991 ( Pmc/Corpus ); précédent : 000990; suivant : 000992Influenza pandemic planning for cancer patients
Auteurs : P. M. BattershillSource :
- Current Oncology [ 1198-0052 ] ; 2006.
Abstract
Given that an influenza pandemic is likely within the next few years, the World Health Organization has recommended that policymakers take action to mitigate the consequences of such a pandemic. Because of the increased risk of patients with cancer developing complications of influenza, policymakers in cancer care should immediately begin planning for changes to resource allocation, clinical care, and the consent process during a pandemic.
Url:
PubMed: 17576451
PubMed Central: 1891185
Links to Exploration step
PMC:1891185Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza pandemic planning for cancer patients</title><author><name sortKey="Battershill, P M" sort="Battershill, P M" uniqKey="Battershill P" first="P. M." last="Battershill">P. M. Battershill</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">17576451</idno><idno type="pmc">1891185</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891185</idno><idno type="RBID">PMC:1891185</idno><date when="2006">2006</date><idno type="wicri:Area/Pmc/Corpus">000991</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000991</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Influenza pandemic planning for cancer patients</title><author><name sortKey="Battershill, P M" sort="Battershill, P M" uniqKey="Battershill P" first="P. M." last="Battershill">P. M. Battershill</name></author></analytic><series><title level="j">Current Oncology</title><idno type="ISSN">1198-0052</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Given that an influenza pandemic is likely within the next few years, the World Health Organization has recommended that policymakers take action to mitigate the consequences of such a pandemic. Because of the increased risk of patients with cancer developing complications of influenza, policymakers in cancer care should immediately begin planning for changes to resource allocation, clinical care, and the consent process during a pandemic.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Oncol</journal-id><journal-id journal-id-type="publisher-id">CO</journal-id><journal-title>Current Oncology</journal-title><issn pub-type="ppub">1198-0052</issn><publisher><publisher-name>Multimed Inc.</publisher-name> <publisher-loc>66 Martin St. Milton, ON, Canada L9T 2R2</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17576451</article-id><article-id pub-id-type="pmc">1891185</article-id><article-id pub-id-type="publisher-id">co13_4p119</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Influenza pandemic planning for cancer patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Battershill</surname><given-names>P.M.</given-names></name><degrees>MD</degrees><xref ref-type="corresp" rid="c1-co13_4p119"></xref></contrib></contrib-group><author-notes><corresp id="c1-co13_4p119"><bold><italic>Correspondence to: </italic></bold>Peter Malcolm Battershill, 2410 Lee Avenue, Victoria, British Columbia V8S 1H7. <bold><italic>E-mail:</italic></bold><email>pbatters@bccancer.bc.ca</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2006</year></pub-date><volume>13</volume><issue>4</issue><fpage>119</fpage><lpage>120</lpage><copyright-statement>2006 Multimed Inc.</copyright-statement><copyright-year>2006</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><p>Given that an influenza pandemic is likely within the next few years, the World Health Organization has recommended that policymakers take action to mitigate the consequences of such a pandemic. Because of the increased risk of patients with cancer developing complications of influenza, policymakers in cancer care should immediately begin planning for changes to resource allocation, clinical care, and the consent process during a pandemic.</p></abstract><kwd-group><kwd>Influenza</kwd><kwd>pandemic</kwd><kwd>planning</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>1. INTRODUCTION</title><p>The World Health Organization (<sc>who</sc>) continues to report new cases of human infection with the H5N1 avian influenza virus in Turkey and Southeast Asia. The next influenza pandemic may not involve the H5N1 strain, but given past epidemiologic patterns, emergence of a new pandemic strain in the near future is likely. The <sc>who</sc> has recommended that policymakers take action to mitigate the consequences of such an event <xref ref-type="bibr" rid="b1-co13_4p119">1</xref>. National, regional, and institutional plans have been developed, but I am aware of none that have addressed the unique needs of patients with cancer.</p><p>Cancer patients are at increased risk of developing complications of influenza—specifically, bacterial superinfection. Patients with cancer face all the risks of the general population during a pandemic and also have increased susceptibility to infection as a result of their illness. For example, myeloma and chronic lymphocytic leukemia are frequently associated with hypogammaglobulinemia; patients with these diseases are therefore at risk for bacterial infections. Increased susceptibility can also result from the general debility caused by cancer. Additionally, many cancer treatments increase the risk of complications of influenza through myelosuppression. These unique risks mean that policymakers in cancer care must urgently develop plans for changes in resource allocation, clinical practice, and consent procedures during an influenza pandemic.</p></sec><sec sec-type="discussion"><title>2. DISCUSSION</title><sec><title>2.1 Resource Allocation</title><p>It is estimated that 15%–35% of the general population will become clinically ill during an influenza pandemic <xref ref-type="bibr" rid="b2-co13_4p119">2</xref>. The percentage of health care workers becoming ill could be higher than that of the general population because of occupational exposure to the virus. Preparedness plans therefore prioritize health care workers for influenza vaccination and prophylaxis with antiviral medications. Despite these interventions, many health care workers will be unavailable because of illness, fear of occupational exposure to influenza, and illness within their own families. With a reduced workforce, a reduction in the number of cancer treatments delivered is an inevitability. Thus, rationing of oncology services will be a reality.</p><p>We will have to make difficult decisions if the workforce is reduced to 85% of normal. At 65% of normal staffing, the decisions about who will receive treatment will be agonizing. Clearly we will strive to deliver potentially curative treatments. Not so obvious is how we will manage palliative therapies. We may need to modify our concept of futility. For example, should we give first- and second-line, but not third-line, metastatic chemotherapy treatments? Patients unable to receive chemotherapy in such circumstances will still need expert supportive care; palliative services will, however, be similarly strained during a pandemic.</p><p>Issues of distributive justice will be front and centre in the discussions of how we treat cancer patients during a pandemic. Perhaps we should give preference to therapies that are less labour-intensive, allowing us to treat more patients. For example, in the adjuvant treatment of early breast cancer, the use of doxorubicin and cyclophosphamide (<sc>ac</sc> chemotherapy) for 4 cycles may allow us to treat more patients than would be possible if we used chemotherapy regimens requiring 6 or 8 cycles. The <sc>ac</sc> chemotherapy may be slightly less effective in preventing recurrence of the cancer in any one individual, but if more people can be treated, the less effective treatment may be justified.</p><p>Cancer care providers should assess their current service capacity. Institutions currently functioning near capacity will have greater difficulty providing service when staff levels are decreased. Clearly, these institutions will have greater challenges in resource allocation.</p></sec><sec><title>2.2 Changes to Clinical Practice</title><p>In addition to standard measures of influenza prevention—vaccination, careful attention to hand washing, and antiviral prophylaxis for people at high risk—changes to standard oncology practice may lessen the risks to cancer patients. Health care providers must always balance the risks of harm with the potential for benefit when making treatment recommendations.</p><p>During a pandemic, the potential for benefit with chemotherapy would be unchanged, but the risk of harm would be increased to a degree that cannot be readily quantified. Neutropenic patients who contract influenza will be at significantly increased risk of harm from bacterial superinfection. The use of hematopoietic colony–stimulating factors to prevent chemotherapy-induced neutropenia is not routine with most chemotherapy protocols <xref ref-type="bibr" rid="b3-co13_4p119">3</xref>. Greater use of such factors to prevent neutropenia may be reasonable during a pandemic, but would increase the cost of treatment at a time when health care budgets will be severely strained. Increased use of prophylactic antibiotics may prevent some superinfections <xref ref-type="bibr" rid="b4-co13_4p119">4</xref>, but at the cost of increased bacterial resistance and antibiotic related diarrhea.</p><p>Many patients will not be able to afford the extra costs of the colony-stimulating factors and antibiotics, raising the possibility that an influenza pandemic would worsen the already existing health disparities based on socioeconomic status. To ensure a just distribution of resources, planners should incorporate an ethical component into their planning as suggested in the report by the Joint Centre for Bioethics at the University of Toronto <xref ref-type="bibr" rid="b5-co13_4p119">5</xref>. The suggested framework identifies key ethical issues and provides a 15-point guide for ethical influenza pandemic planning.</p></sec><sec><title>2.3 Consent Issues</title><p>Cancer patients need to know that myelosuppressive treatment could carry greater risk during a pandemic. In addition to the concerns mentioned earlier, the usual supports for patients with febrile neutropenia will be severely limited. Access to hospital beds will be limited both by increased demand and by staff illness. In this circumstance, patients may well make an informed choice for a potentially less efficacious but less myelosuppressive treatment.</p></sec></sec><sec sec-type="conclusions"><title>3. CONCLUSIONS</title><p>Policymakers in cancer care should immediately start planning for cancer care delivery during an influenza pandemic. However, no single plan will suffice for all oncology practices. The needs of a pediatric service will differ from the needs of a bone-marrow transplant service.</p><p>We have the opportunity now to prepare for cancer care provision during a pandemic. To assure optimal treatment and fair distribution of resources, this planning should start immediately.</p></sec></body><back><ref-list><title>4. REFERENCES</title><ref id="b1-co13_4p119"><label>1</label><citation citation-type="other">World Health Organization (WHO), Communicable Disease Surveillance and Response, Global Influenza Programme. <italic>Responding to the Avian Influenza Pandemic Threat. Recommended Strategic Actions</italic> [WHO checklist for pandemic preparedness planning]. WHO/CDS/CSR/GIP/2005.8. Geneva: WHO; 2005. [Available online at: <ext-link ext-link-type="uri" xlink:href="www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_05_8-EN.pdf">www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_05_8-EN.pdf</ext-link>; cited May 31, 2006]</citation></ref><ref id="b2-co13_4p119"><label>2</label><citation citation-type="other">British Columbia Centre for Disease Control (BCCDC). <italic>British Columbia Pandemic Influenza Preparedness Plan: Guidelines for Planning, Response and Recovery.</italic> Version 3. Vancouver: BCCDC; 2005. [Available online at: <ext-link ext-link-type="uri" xlink:href="www.bccdc.org/content.php?item=150">www.bccdc.org/content.php?item=150</ext-link>; cited May 31, 2006]</citation></ref><ref id="b3-co13_4p119"><label>3</label><citation citation-type="other"><italic>Clinical practice guidelines of the American Society of Clinical Oncology</italic> (<sc>asco</sc><italic>).</italic> Alexandria, VA: <sc>asco</sc>; 2006. [Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.asco.org/portal/site/ASCO/menuitem.c543a013502b2a89de912310320041a0/?vgnextoid=f7af8c393c458010VgnVCM100000ed730ad1RCRD">http://www.asco.org/portal/site/ASCO/menuitem.c543a013502b2a89de912310320041a0/?vgnextoid=f7af8c393c458010VgnVCM100000ed730ad1RCRD</ext-link>; cited May 31, 2006]</citation></ref><ref id="b4-co13_4p119"><label>4</label><citation citation-type="journal"><person-group><name><surname>Bucaneve</surname><given-names>G</given-names></name><name><surname>Micozzi</surname><given-names>A</given-names></name><name><surname>Menichetti</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia</article-title><source>N Engl J Med</source><year>2005</year><volume>353</volume><fpage>977</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">16148283</pub-id></citation></ref><ref id="b5-co13_4p119"><label>5</label><citation citation-type="other">University of Toronto, Joint Centre for Bioethics, Pandemic Influenza Working Group. <italic>Stand on Guard for Thee: Ethical Considerations in Preparedness Planning for Pandemic Influenza.</italic> Toronto: University of Toronto; 2005. [Available online at: <ext-link ext-link-type="uri" xlink:href="www.utoronto.ca/jcb/home/documents/pandemic.pdf">www.utoronto.ca/jcb/home/documents/pandemic.pdf</ext-link>; cited May 31, 2006]</citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000991 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000991 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1891185
|texte= Influenza pandemic planning for cancer patients
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:17576451" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |